Edition:
United Kingdom

Sorrento Therapeutics Inc (SRNE.OQ)

SRNE.OQ on NASDAQ Stock Exchange Capital Market

4.30USD
21 Sep 2018
Change (% chg)

$-0.15 (-3.37%)
Prev Close
$4.45
Open
$4.40
Day's High
$4.45
Day's Low
$4.05
Volume
2,982,185
Avg. Vol
470,221
52-wk High
$10.65
52-wk Low
$1.70

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 3.91 -0.734
Mar '18 6.25 -0.383
FY 2017 Dec '17 20.41 0.572
Sep '17 121.91 -0.027
Jun '17 4.66 -0.202
Mar '17 4.87 -0.453
FY 2016 Dec '16 4.02 -0.204
Sep '16 2.24 0.239
Jun '16 0.90 -0.931
Mar '16 0.99 -0.412
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 3.72 3.95 3.50 7.25
Quarter Ending Dec-18 3 3.49 4.20 2.39 8.55
Year Ending Dec-18 3 17.37 18.31 16.26 40.37
Year Ending Dec-19 3 27.72 32.22 25.06 109.50
Earnings (per share)
Quarter Ending Sep-18 3 -0.19 -0.16 -0.21 -0.19
Quarter Ending Dec-18 3 -0.19 -0.16 -0.22 -0.18
Year Ending Dec-18 3 -1.40 -1.34 -1.46 -0.64
Year Ending Dec-19 3 -0.68 -0.56 -0.78 -0.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta 1.68 0.93 0.89
Price to Sales (TTM) 8.72 114.98 5.74
Price to Book (MRQ) 1.49 15.51 5.00
Price to Tangible Book (MRQ) -- 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 16.91 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 417.18 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago 264.92 80.36 5.64
Sales - 5 Yr. Growth Rate 72.80 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 78.33 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago 67.70 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate 45.51 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 0.76 5.46 3.03
LT Debt to Equity (MRQ) 28.72 35.27 12.51
Total Debt to Equity (MRQ) 28.72 37.09 16.85
Interest Coverage (TTM) -39.19 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 87.11 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -440.86 -- --
EBITD - 5 Yr. Avg -1,306.82 -600.62 10.68
Operating Margin (TTM) -396.65 -759.68 4.33
Operating Margin - 5 Yr. Avg. -1,318.88 -621.65 6.11
Pre-Tax Margin (TTM) -255.23 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -804.66 -627.35 6.51
Net Profit Margin (TTM) -229.98 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -996.11 -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 102,604 23,229,030 860,305,024
Net Income/Employee (TTM) -235,968 3,144,146 101,198,978
Receivable Turnover (TTM) 9.74 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.04 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -9.87 -0.15 11.13
Return on Assets - 5 Yr. Avg. -22.28 3.51 12.40
Return on Investment (TTM) -12.13 1.79 14.61
Return on Investment - 5 Yr. Avg. -24.93 2.56 16.13
Return on Equity (TTM) -29.69 3.28 16.33
Return on Equity - 5 Yr. Avg. -45.57 3.43 17.39
  1 Year 3 Year 5 Year
Sales % 77.60 160.69 72.80
EPS (TTM) % 2.53 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Sorrento Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.86 -0.69 99 52
13 Week -7.69 -12.19 73 66
26 Week -40.98 -45.47 29 80
52 Week -76.62 -80.19 9 50
YTD -63.27 -67.74 12 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.51%
# of Holders: 134
Total Shares Held: 30,941,590
3 Mo. Net Change: 6,872,803
# New Positions: 60
# Closed Positions: 30
# Increased Positions: 97
# Reduced Positions: 44
# Net Buyers: 53
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.